MMI announces global imaging services collaboration with Micron
Learn MoreWith MMI and Micron’s joint forces, we have significantly expanded our network of global key clinical thought leaders, imaging experts, and clinician reviewers that are available to support sponsors in the design and execution of their trials. In addition to the scientific experts, we have also expanded our repertoire of image analysis techniques and methodologies, including proprietary ones, to support a wide range of imaging endpoints.
MMI, based in Houston, TX, USA, and Micron, based in Tokyo, Japan, have successfully trained and supported more than 10,000 sites globally to collect high-quality imaging for clinical trials. With staff in the eastern and western hemispheres, we are able to communicate with sponsors and sites quickly and efficiently, in their local time zones, to enable faster study start-up and efficient execution.
Our company cultures are aligned to prioritize customer satisfaction, flexibility, and high-quality science. As two nimble, lean organizations, we value efficiency and consistent service delivery.
We have the clinical and scientific expertise to support all major imaging modalities in clinical trials across a wide range of therapeutic areas. From advanced quantitative analysis techniques for X-ray, MR, and CT to functional imaging in PET/SPECT, our experts will guide your sites on image acquisition and recommend the most efficient, validated, state-of-the-art imaging endpoints for your studies.
Have more questions about the MMI-Micron collaboration? Click the button below to reach out to our team! For more information about our scientific expertise, please visit our Therapeutic Area pages.